Is waist-to-height ratio a better predictor of hypertension and type 2 diabetes than body mass index and waist circumference in the Chilean population?


Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
Historique:
received: 08 04 2020
revised: 15 06 2020
accepted: 15 06 2020
pubmed: 28 8 2020
medline: 24 6 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

The aim of this study was to identify which anthropometric measurement (body mass index [BMI], waist circumference [WC], or waist-to-height ratio [WHtR]) is a better predictor of type 2 diabetes and hypertension in the Chilean population. The study included 13 044 participants (59.7% women) from the Chilean National Health Surveys conducted in 2003, 2009-2010, and 2016-2017. BMI, WC, and WHtR were the anthropometric measurements evaluated. Hypertension was defined as systolic blood pressure ≥140 mm Hg and diastolic blood pressure ≥90 mm Hg or on medication for hypertension. Diabetes was defined as fasting glucose ≥7 mmol/L or on medication for diabetes. The receiver operating characteristics (ROC) curve and the area under curve (AUC) were computed to derive the specificity and sensitivity using a bootstrapping approach. Compared with BMI and WC, WHtR was the anthropometric measurement with the highest AUC curve in both sexes for hypertension (AUC for women: 0.70; 95% confidence interval [CI], 0.67-0.73; AUC for men: 0.71; 95% CI, 0.69-0.74) and diabetes (AUC for women: 0.71; 95% CI, 0.66-0.77; AUC for men: 0.71; 95% CI, 0.67-0.76). The sex-specific cutoff points of WHtR to predict hypertension were 0.59 and 0.55 for women and men, respectively. Those used to predict diabetes were 0.60 and 0.58 for women and men, respectively. WHtR was a better predictor of hypertension and diabetes than BMI and WC in Chile. The definition of cutoff points specific for the Chilean population could be implemented in future screening programs aiming to identify high-risk individuals.

Identifiants

pubmed: 32847773
pii: S0899-9007(20)30215-X
doi: 10.1016/j.nut.2020.110932
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110932

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Fanny Petermann-Rocha (F)

Institute of Health and Wellbeing, On behalf of ELHOC-Chile Research Consortium, Glasgow, United Kingdom; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. Electronic address: f.petermann-rocha.1@research.gla.ac.uk.

Natalia Ulloa (N)

Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile; Departamento de Bioquímica Clínica e Inmunología, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile.

María Adela Martínez-Sanguinetti (MA)

Instituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.

Ana María Leiva (AM)

Instituto de Anatomía, Histología y Patología, Facultad de Farmacia, Universidad Austral de Chile, Valdivia, Chile.

Miquel Martorell (M)

Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile; Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepción, Concepción, Chile.

Marcelo Villagrán (M)

Department of Basic Science, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Claudia Troncoso-Pantoja (C)

Centro de Investigación en Educación y Desarrollo (CIEDE-UCSC), Departamento de Salud Pública, Facultad de Medciina, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Frederick K Ho (FK)

Institute of Health and Wellbeing, On behalf of ELHOC-Chile Research Consortium, Glasgow, United Kingdom.

Carlos Celis-Morales (C)

Institute of Health and Wellbeing, On behalf of ELHOC-Chile Research Consortium, Glasgow, United Kingdom; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; Centre of Exercise Physiology Research (CIFE), Universidad Mayor, Chile; Laboratorio de Rendimiento Humano, Grupo de Estudio en Educación, Actividad Física y Salud (GEEAFyS), Universidad Católica del Maule, Talca, Chile.

Alonso Pizarro (A)

University of Basilicata, Matera, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH